WARNING:
JavaScript is turned OFF. None of the links on this concept map will
work until it is reactivated.
If you need help turning JavaScript On, click here.
This Concept Map, created with IHMC CmapTools, has information related to: IBD m1.5, Signs and symptoms assessment scale include PROs, Repeated concepts/instances (e.g. Biopsy) are denoted by dotted outline, Concepts with open questions are denoted in red font, Concepts (e.g. Mayo score) are denoted by solid round-edged rectangle, Endoscopy results are_taken_from Timepoints, Clinical remission is_measured_by Endoscopic assessment scale, instance of concepts (e.g. 24 hour period) are denoted by solid square-edged rectangle, Histology assessment is_conducted_at Central Lab, Clinical remission determines_scope_of Corticosteroid-free remission (CSFR), Observation or Assessment is used to monitor the state of Physiological Process, Therapeutic Efficacy Point is the intersection of Observation or Assessment, Efficacy endpoints include Clinical remission, Endoscopy results include Histology assessment, Histology assessment are_factored_into Endoscopy results, Endoscopy results include Visual assessment, Efficacy endpoints include Mucosal improvement, Main concepts (e.g. Clinical response) are denoted by Larger bold font with thicker outline, Efficacy endpoints is_compared_between Time periods, Visual assessment is_conducted_at Central Lab, Therapeutic Efficacy Point is the intersection of Physiological Process